Comprehensive proteomics and meta-analysis of COVID-19 host response
© 2023. Springer Nature Limited..
COVID-19 is characterised by systemic immunological perturbations in the human body, which can lead to multi-organ damage. Many of these processes are considered to be mediated by the blood. Therefore, to better understand the systemic host response to SARS-CoV-2 infection, we performed systematic analyses of the circulating, soluble proteins in the blood through global proteomics by mass-spectrometry (MS) proteomics. Here, we show that a large part of the soluble blood proteome is altered in COVID-19, among them elevated levels of interferon-induced and proteasomal proteins. Some proteins that have alternating levels in human cells after a SARS-CoV-2 infection in vitro and in different organs of COVID-19 patients are deregulated in the blood, suggesting shared infection-related changes.The availability of different public proteomic resources on soluble blood proteome alterations leaves uncertainty about the change of a given protein during COVID-19. Hence, we performed a systematic review and meta-analysis of MS global proteomics studies of soluble blood proteomes, including up to 1706 individuals (1039 COVID-19 patients), to provide concluding estimates for the alteration of 1517 soluble blood proteins in COVID-19. Finally, based on the meta-analysis we developed CoViMAPP, an open-access resource for effect sizes of alterations and diagnostic potential of soluble blood proteins in COVID-19, which is publicly available for the research, clinical, and academic community.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Nature communications - 14(2023), 1 vom: 22. Sept., Seite 5921 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Babačić, Haris [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 25.09.2023 Date Revised 19.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41467-023-41159-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362364508 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362364508 | ||
003 | DE-627 | ||
005 | 20231226091102.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41467-023-41159-z |2 doi | |
028 | 5 | 2 | |a pubmed24n1207.xml |
035 | |a (DE-627)NLM362364508 | ||
035 | |a (NLM)37739942 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Babačić, Haris |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comprehensive proteomics and meta-analysis of COVID-19 host response |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.09.2023 | ||
500 | |a Date Revised 19.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. Springer Nature Limited. | ||
520 | |a COVID-19 is characterised by systemic immunological perturbations in the human body, which can lead to multi-organ damage. Many of these processes are considered to be mediated by the blood. Therefore, to better understand the systemic host response to SARS-CoV-2 infection, we performed systematic analyses of the circulating, soluble proteins in the blood through global proteomics by mass-spectrometry (MS) proteomics. Here, we show that a large part of the soluble blood proteome is altered in COVID-19, among them elevated levels of interferon-induced and proteasomal proteins. Some proteins that have alternating levels in human cells after a SARS-CoV-2 infection in vitro and in different organs of COVID-19 patients are deregulated in the blood, suggesting shared infection-related changes.The availability of different public proteomic resources on soluble blood proteome alterations leaves uncertainty about the change of a given protein during COVID-19. Hence, we performed a systematic review and meta-analysis of MS global proteomics studies of soluble blood proteomes, including up to 1706 individuals (1039 COVID-19 patients), to provide concluding estimates for the alteration of 1517 soluble blood proteins in COVID-19. Finally, based on the meta-analysis we developed CoViMAPP, an open-access resource for effect sizes of alterations and diagnostic potential of soluble blood proteins in COVID-19, which is publicly available for the research, clinical, and academic community | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Proteome |2 NLM | |
700 | 1 | |a Christ, Wanda |e verfasserin |4 aut | |
700 | 1 | |a Araújo, José Eduardo |e verfasserin |4 aut | |
700 | 1 | |a Mermelekas, Georgios |e verfasserin |4 aut | |
700 | 1 | |a Sharma, Nidhi |e verfasserin |4 aut | |
700 | 1 | |a Tynell, Janne |e verfasserin |4 aut | |
700 | 1 | |a García, Marina |e verfasserin |4 aut | |
700 | 1 | |a Varnaite, Renata |e verfasserin |4 aut | |
700 | 1 | |a Asgeirsson, Hilmir |e verfasserin |4 aut | |
700 | 1 | |a Glans, Hedvig |e verfasserin |4 aut | |
700 | 1 | |a Lehtiö, Janne |e verfasserin |4 aut | |
700 | 1 | |a Gredmark-Russ, Sara |e verfasserin |4 aut | |
700 | 1 | |a Klingström, Jonas |e verfasserin |4 aut | |
700 | 1 | |a Pernemalm, Maria |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 14(2023), 1 vom: 22. Sept., Seite 5921 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2023 |g number:1 |g day:22 |g month:09 |g pages:5921 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-023-41159-z |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2023 |e 1 |b 22 |c 09 |h 5921 |